EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HPV‐Adjusted Feature Screening With FDR Control in Head and Neck Cancer

Atika Farzana Urmi, Chenlu Ke, Dipankar Bandyopadhyay

Biometrical Journal · 2026-06 · 68 (3)

DOI: 10.1002/bimj.70141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrical Journal, online erschienen am 23.05.2026. Verfasst von Atika Farzana Urmi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Human Papillomavirus Viruses, Papillomaviridae, Biometry. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV) is a well‐established prognostic factor in head and neck (HN) cancer, with HPV‐positive patients exhibiting markedly better survival outcomes compared to their HPV‐negative counterparts. While advances in (cancer) genomics have been pivotal to precision medicine, existing gene screening methods for identifying molecular markers to predict survival often fail to account for HPV status. This oversight can result in missing important genes, whose effects are confounded or overshadowed by HPV, thereby limiting the biological interpretability and clinical utility of identified markers. To address these limitations, we propose a novel conditional screening method for ultrahigh‐dimensional right‐censored survival data that adjusts for HPV status. This approach identifies prognostic genes with independent associations with survival while also capturing HPV‐specific interactions and synergistic effects. The proposed method employs a two‐stage, model‐free framework that combines nonparametric statistics for initial screening with a unified false discovery rate (FDR) control procedure to refine feature selection. Simulation studies demonstrate its advantages over existing alternatives. Application of the conditional screening framework to HN cancer data from The Cancer Genome Atlas revealed a set of robust prognostic genes, uncovering new insights into the molecular pathways driving survival outcomes across HPV subgroups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsHuman Papillomavirus VirusesPapillomaviridaeBiometryHumansPrognosisSurvival AnalysisPapillomavirus Infections

Stichwörter der Autor:innen

FDR controlHNSCCconditional screeninghigh‐dimensionalsurvival

Autor:innen und Institutionen

  • Department of Biostatistics, School of Public Health, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Department of Statistical Sciences and Operations Research, Virginia Commonwealth University, Richmond, Virginia, USA.

Förderung

  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Urmi, A. F., Ke, C., & Bandyopadhyay, D. (2026). HPV‐Adjusted Feature Screening With FDR Control in Head and Neck Cancer. Biometrical Journal, 68(3). https://doi.org/10.1002/bimj.70141

Vancouver

Urmi AF, Ke C, Bandyopadhyay D. HPV‐Adjusted Feature Screening With FDR Control in Head and Neck Cancer. Biometrical Journal. 2026;68(3). doi:10.1002/bimj.70141

BibTeX
@article{Urmi2026,
  author = {Urmi, Atika Farzana and Ke, Chenlu and Bandyopadhyay, Dipankar},
  title = {HPV‐Adjusted Feature Screening With FDR Control in Head and Neck Cancer},
  journal = {Biometrical Journal},
  year = {2026},
  volume = {68},
  number = {3},
  doi = {10.1002/bimj.70141}
}
Kostenlos starten →